Harvest Moon Pharmaceuticals (HMP) specializes in the development, manufacture, and out-licensing of specialty pharmaceutical products with a special emphasis on complex generic drug products and biologicals. Our manufacturing and development facilities have been approved by regulatory authorities from the US and EU.
Our goal is to help bring affordable low cost generic pharmaceuticals to regulated markets of the world.
"According to a new analysis conducted by IMS Health and commissioned by the Generic Pharmaceutical Association (GPhA), generic medicines saved the American health care system more than $734 billion in the last decade (1999-2008), with approximately $121 billion in savings in 2008 alone. "
Harvest Moon Pharma has access to an international marketing sales force from